Patient Group Directions

Applied filters

Patient Group Directions

Care Setting (13)
- Emergency medicine and urgent care (5)
- Occupational Health (6)
- Palliative and End of Life Care (1)
- Primary Care (1)
Events (1)
- Past Events (1)
Guidance (140)
- Administering (10)
- Dosing (2)
- Implementation (12)
- Medication Safety (1)
- Patient Group Directions (140)
- Policy, Commissioning and Managerial (8)
- Safety in Pregnancy (5)
- Service advice and planning (3)
- Supply (11)
- Unlicensed medicines (2)
Medicine (78)
- Aciclovir (2)
- Amoxicillin (1)
- Aspirin (1)
- Azithromycin (1)
- Benzylpenicillin (2)
- Ceftriaxone (1)
- Clarithromycin (5)
- Clotrimazole (2)
- Copper (1)
- Diamorphine (1)
- Diazepam (2)
- Doxycycline (2)
- Emtricitabine + Tenofovir disoproxil (1)
- Erythromycin (5)
- Estradiol + Dienogest (1)
- Estradiol + Nomegestrol (1)
- Ethinylestradiol + Desogestrel (1)
- Ethinylestradiol + Drospirenone (1)
- Ethinylestradiol + Etonogestrel (1)
- Ethinylestradiol + Gestodene (1)
- Ethinylestradiol + Levonorgestrel (1)
- Ethinylestradiol + Norelgestromin (1)
- Ethinylestradiol + Norethisterone (1)
- Ethinylestradiol + Norgestimate (1)
- Etonogestrel (2)
- Flucloxacillin (2)
- Fluconazole (1)
- Flumazenil (1)
- Fluticasone (1)
- Folic acid (1)
- Fusidic acid (1)
- Gadobutrol (1)
- Gadoteric acid (1)
- Gadoteridol (1)
- Gadoxetic acid (1)
- Hydrogen peroxide (1)
- Imiquimod (1)
- Influenza vaccine (3)
- Iodixanol (1)
- Iohexol (1)
- Iomeprol (1)
- Iopamidol (1)
- Ioversol (1)
- Ketamine (1)
- Levonorgestrel (2)
- Lidocaine (5)
- Lidocaine + Prilocaine (1)
- Medroxyprogesterone (2)
- Meglumine gadobenate (1)
- Metronidazole (1)
- Midazolam (2)
- Mifepristone (1)
- Misoprostol (1)
- Mometasone (1)
- Morphine (1)
- Nitrofurantoin (1)
- Phenoxymethylpenicillin (2)
- Podophyllotoxin (1)
- Prilocaine (1)
- Progesterone (1)
- Raltegravir (1)
- Sodium chloride (1)
- Tenofovir disoproxil + Emtricitabine (1)
- Terbutaline (1)
- Tramadol (1)
- Tranexamic acid (1)
- Trimethoprim (1)
- Ulipristal (1)
- Valaciclovir (1)
- Varenicline (1)
Medicines planning (21)
- Patient Group Direction Planning (21)
Publications (94)
- Explainer videos (4)
- Research and audits (3)
- Summary advice (10)
- Templates (77)
Specialty (69)
- Infection and infectious diseases (26)
- Neurological disorders (1)
- Obstetrics and gynaecology (1)
- Public Health (1)
- Radiology (11)
- Renal and urologic disorders (2)
- Reproductive health (14)
- Respiratory disorders (13)
- Sexual health (12)
- Skin disorders (10)
- Smoking cessation (1)
- Vaccinating (3)
Training and Development (6)

Benzylpenicillin for Group B Streptococcus for use in neonates

19 January 2023SPS PGD template for the intrapartum administration of benzylpenicillin for prevention of early-onset Group B Streptococcus (GBS) infection in neonates.

How to develop a Patient Group Direction

9 June 2022A guide to help organisations and individuals navigate all stages of the PGD development process.

Delegating PGD authorisation by a Local Authority

7 March 2022It is not permitted for a Local Authority to delegate the authorisation of Patient Group Directions using a Section 75 partnership agreement.

Folic acid 5mg tablets for use during pregnancy

9 February 2022SPS PGD template for the supply of folic acid 5mg tablets to reduce risk of neural tube defect or compensate for increased folate demand during pregnancy.

Aspirin tablets for use within antenatal and maternity services

9 February 2022SPS PGD template for the supply of aspirin tablets to individuals at risk of pre-eclampsia during pregnancy.

Patient Group Direction use in remote consultations

3 February 2022Patient Group Directions (PGDs) may be used to supply medicines via remote consultations. Advice on clinical assessment and supply is provided.

Managing PGDs following organisational change

3 February 2022Advice on the management of PGDs when organisations merge, cease to exist or services are transferred to a new provider to ensure safe care and good governance

Patient Group Directions e-learning programme

8 December 2021E-learning developed by SPS in partnership with UKHSA, HEE and eLfH to support professionals who use, develop, authorise, review or update PGDs.

Including more than one medicine in a Patient Group Direction

2 December 2021This article summarises the considerations required if more than one medicine is included within a single PGD.

Supply and/or administration of Controlled Drugs under a PGD

16 November 2021The legal position on the supply and/or administration of controlled drugs under Patient Group Directions is summarised

SPS - Specialist Pharmacy Service

NHS